GenericsWeb provides patent intelligence to the world’s leading pharmaceutical companies, allowing their customers to significantly reduce the risk of developing patent-infringing pharmaceuticals for global markets, and identify when and where they can launch products. With headquarters in Sydney, and customer support offices in North America and Europe, GenericsWeb boasts 50% of the world’s top 10 generics companies as key customers, including global heavyweights such as Pfizer, Novartis/Sandoz, Hospira, Mylan, Sanofi-Aventis, Dr Reddy’s, Amgen and Baxter.